Randomized, double-blind, placebo-controlled Phase I study in healthy individuals on autotaxin-inhibition with MJK2134025 in single-ascending, as well as multiple intravenous doses

What you commit to

• Study type: Interventional · Phase 1
• Planned participants: 82
• 1 site in 1 country
• Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.

AI-kivonat: who the study is looking for

Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for healthy men aged 18 to 64 to test the drug MJK2134025, given into a vein in single and repeated doses.

Age

18 to 64 years

Sex

Men only

This trial only enrols healthy participants. The registry sentence this rests on: Randomized, double-blind, placebo-controlled Phase I study in healthy individuals on autotaxin-inhibition with MJK2134025 in single-ascending, as well as multiple intravenous doses

Read by machine on 9 Nov 2026.

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

Are you the coordinator? Confirm the details